Brain Motor cortex atrophy

Quibim

Quibim’s Motor cortex atrophy automatically quantifies the volumes of the right and left precentral gyrus and compares the results with a set of healthy patients. The suite can be used to aid early diagnosis and monitoring of patients with a Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative pathology, which causes movement disorders.
Product specifications Information source: Vendor
Last updated: May 17, 2020
General
Product name Brain Motor cortex atrophy
Company Quibim
Subspeciality Neuro
Modality MR
Disease targeted Amyotrophic lateral sclerosis (ALS)
Key-features Absolute volume, Relative volume, Brain parenchyma fraction
Suggested use Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population Patients associated with Temporal lobe epilepsy (TLE)
Input MRI T1 GRE 3D T1 Fast Gradient Echo
Input format
Output One-page structured report: One-page structured report: 3D precentral gyrus render, precentral gyrus segmentation, table with volume statistics, brain parenchyma fraction (BPF), normative graphs of volume and BPF
Output format DICOM Secondary Capture / PDF
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition
Processing time > 10 minutes
Certification
CE
Certified, Class IIa , MDD
FDA
No or not yet
Market presence
On market since 01-2019
Distribution channels
Countries present (clinical, non-research use) 6
Paying clinical customers (institutes) 5+
Research/test users (institutes)
Pricing
Pricing model License
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers